22 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28523109	79	Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4.	Glaxosmithkline
27964995	42	Synthesis and optimization of novela-phenylglycinamides as selective TRPM8 antagonists.	Kissei Pharmaceutical
26235950	41	Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.	Renovis
25893043	36	Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain.	Pfizer
25455494	172	Effect of acyclic monoterpene alcohols and their derivatives on TRP channels.	Sapienza University Of Rome
25455182	52	Identification of a novel 2-pyridyl-benzensulfonamide derivative, RQ-00203078, as a selective and orally active TRPM8 antagonist.	Raqualia Pharma
24884675	70	Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.	Genomics Institute Of The Novartis Research Foundation
24597733	57	Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.	Amgen
24080460	24	Serendipity in drug-discovery: a new series of 2-(benzyloxy)benzamides as TRPM8 antagonists.	Pfizer
24055075	42	Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1'H-spiro[chromene-2,4'-piperidine]-1'-carboxamides as TRPM8 antagonists.	Glenmark Pharmaceuticals
23121096	86	Ion channels as therapeutic targets: a drug discovery perspective.	Pfizer
21128593	44	Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonists.	Janssen Pharmaceutica
20570528	34	Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists.	Abbott Laboratories
20356305	151	Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents.	Ferrara University
22330635	25	Discovery of vinylcycloalkyl-substituted benzimidazole TRPM8 antagonists effective in the treatment of cold allodynia.	Janssen Pharmaceutica
21634377	73	Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.	Amgen
20965726	20	5-benzyloxytryptamine as an antagonist of TRPM8.	Renovis
17293875	3	TRPM8 voltage sensor mutants reveal a mechanism for integrating thermal and chemical stimuli.	Ku Leuven